Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations

Background: DNA methyltransferase 3A (DNMT3A) plays a unique role in hematopoiesis and acute myeloid leukemia (AML) pathogenesis. While the influences of DNMT3A mutation subtypes are still under debate. Purpose: Exploration of the clinical and molecular differences between AML patients carrying DNMT...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Yang, Li, Shen, Ke'Feng, Zhang, Mei'Lan, Zhang, Wei, Cai, Hao'Dong, Lin, Li'Man, Long, Xiao'Lu, Xing, Shu'Gang, Tang, Yang, Xiong, Jie, Wang, Jia'Chen, Li, Deng'Ju, Zhou, Jian'Feng, Xiao, Min
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6821681/
https://ncbi.nlm.nih.gov/pubmed/31709191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01133
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak